Safe and Effective Administration of Caplacizumab in COVID-19-Associated Thrombotic Thrombocytopenic Purpura.
Bruzzese A, Vigna E, Terzi D, Greco S, Martino EA, Vangeli V, Mendicino F, Lucia E, Olivito V, Labanca C, Morelli R, Neri A, Morabito F, Zinno F, Mastroianni A, Gentile M.
Bruzzese A, et al. Among authors: morelli r.
Hematol Rep. 2023 Jul 20;15(3):448-453. doi: 10.3390/hematolrep15030046.
Hematol Rep. 2023.
PMID: 37489376
Free PMC article.